AzTrials
AzTrials

Inguinal HerniaNCT03904888

Conventional Versus Robot Assisted Laparoscopic Inguinal Hernia Repair

A study testing r-TAPP, l-TAPP and local anesthetics in people with Inguinal Hernia, run by Algemeen Ziekenhuis Maria Middelares at 1 site in Belgium.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

Evaluate the early postoperative course of patients undergoing laparoscopic inguinal hernia repair with either a conventional or a robot assisted approach and with or without the injection of the trocar wounds with a local anesthetic. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Inguinal Hernia
What is being tested?
r-TAPP, l-TAPP and local anesthetics
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
200 participants
Where
1 siteBelgium
Study dates
23 Sep 2019to Dec 2029
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • adult patients presenting with a bilateral inguinal hernia planned for a minimal invasive laparoscopic repair

Who cannot join

  • Age below 18 years
  • unilateral groin hernia repair
  • incarcerated hernias
  • open hernia repair
  • no informed consent
  • pregnant women
  • ASA score 4 or more
  • patient included in another study.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Filip Muysoms, MD,PhD contact

+32477325710

filip.muysoms@gmail.com

Rita Baumgartner, MSc contact

0494845897

rita.baumgartner@azmmsj.be

Belgium1 site, 1 recruiting
  • AZ Maria Middelares

    Ghent, 9000

    Filip Muysoms, MD, PhD, 0032-92467400, filip.muysoms@azmmsj.be

    Rita Baumgartner, MSc, 0032 - 92467451, rita.baumgartner@azmmsj.be

    Recruiting

Other trials in Belgium

About this study

Evaluate the early postoperative course of patients undergoing laparoscopic inguinal hernia repair with either a conventional or a robot assisted approach and with or without the injection of the trocar wounds with a local anesthetic.

Read the detailed description

Introduction Inguinal hernia is a common disease with a high lifetime risk; 27 % for men and 3% for women. These hernias can be categorized as lateral, medial or femoral according to the classification of the European Hernia Society. The manifestations may vary from an asymptomatic swelling till an incarcerated or strangulated hernia requiring an urgent operation.

The introduction of mesh reinforcement for groin hernia repair has resulted in reducing the rate of recurrences and chronic pain. Moreover, laparoscopic repair techniques made it possible to place the mesh in de pre-peritoneal space by a transperitoneal (TAPP) or pre-peritoneal (TEP) approach. These minimally invasive techniques are not only associated with less chronic pain or numbness, but also with an earlier return to normal activities or work. A favor for one of the two techniques has not yet been proven.

At the Hernia Center Maria Middelares a laparoscopic transabdominal pre-peritoneal (l-TAPP) approach is favored in the majority of adult patients presenting with a groin hernia since more than 20 years. The investigators have adopted a technique using one large pre-peritoneal self-fixating mesh that covers both groins in bilateral laparoscopic repairs. In September 2016 the investigators started to use a robot assisted laparoscopic approach (r-TAPP) for groin hernia repair and built proficiency in this technique with 120 cases operated in the first year of adoption. Barriers to adopting robot assisted groin hernia repair are insufficient availability of the robot, perception of longer operative time, perceived lack of clinical benefit for the patient and increased cost for instrumentation.

In a learning curve study using the daVinci Xi robotic system the investigators have shown that after about 25 cases the skin to skin operating time for r-TAPP equals the skin to skin operating time for l-TAPP. Similarly the overall OR time (patient in and out of the OR) is not increased for r-TAPP compared to l-TAPP if the whole team including nurses and anesthetists have become proficient in robotic assisted surgery (Clinical Trials identifier: NCT0975401).

The investigators standard technique for repair of bilateral groin hernias is to use a self-fixating mesh placed in a pre-peritoneal position with a TAPP approach. The investigator prefers to use one large mesh covering the myopectineal orifice of both groins with a width of 28 cm and a length of 13 cm. The mesh used is a Progrip self-fixating mesh (Medtronic, US), which is a monofilament polyester mesh to which resorbable PLA grips have been added to fixate the mesh to the underlying tissue during the period of mesh ingrowth and incorporation. This technique has been studied in our department in a prospective study focusing on early and one year outcome and has shown favorable results (Clinical Trials identifier: NCT02525666 ).

This study aims to differentiate between the early postoperative recovery after laparoscopic repair of bilateral groin hernias treated either with r-TAPP or with l-TAPP.

A total of 200 male and female patients will be entered in the trial in Maria Middelares Ghent, for which an inclusion period of 24 months is anticipated. Patients will be screened and invited to participate at the outpatient clinic.

Study set-up:

  • Based on clinical examination and/or ultrasonography 200 patients will be selected.
  • Preoperative, during the outpatients' visit, patients will be asked to sign Informed Consent and to fill out the EuraHS-QoL (Quality of Life score) questionnaire.
  • Patients will be randomized, to receive either conventional laparoscopic repair (100 patients) or robot assisted laparoscopic repair (100 patients). Patients will be blinded to the surgical method.
  • Furthermore patients will be randomized to either receive local anesthetics (50 patients in each group) or none (50 patients in each group)
  • Postoperatively, patients will be invited for clinical follow-up with quality of life evaluations with the EuraHS-QoL score at 1 month and at 12 months.
Conditions
Inguinal Hernia
Being tested
r-TAPP, l-TAPP, local anesthetics
Medical subject headings
Hernia, Inguinal

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • r-TAPPProcedure or surgery

    Robot-assisted repair

  • l-TAPPProcedure or surgery

    Laporoscopic repair

  • local anestheticsProcedure or surgery

    local anesthetics will be administred

Study groups in NCT03904888
Study groupRoleWhat they receive
l-TAPP without local anestheticsOtherThese patients will undergo a laparoscopic surgery without local anaesthetics.
Receives: Procedure: l-TAPP
l-TAPP with local anestheticsOtherThese patients will undergo a laparoscopic surgery with local anaesthetics.
Receives: Procedure: l-TAPP; Procedure: local anesthetics
r-TAPP without local anestheticsOtherThese patients will undergo a robot-assisted surgery without local anaesthetics.
Receives: Procedure: r-TAPP
r-TAPP with local anestheticsOtherThese patients will undergo a robot-assisted surgery with local anaesthetics.
Receives: Procedure: r-TAPP; Procedure: local anesthetics

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. change in PADSS score

    Time postoperative for the patient to get fit for discharge as determined by a PADSS score (Post Anesthesia Discharge Scoring System) to reach ≥ 9 (10 is maximum). The score will be taken at 2 hourly intervals after surgery (0 hours,2 hours,4 hours,6 hours,8 hours,10 hours,12 hours,14 hours,16 hours,18 hours,20 hours,22 hours,24 hours) up to 24 hours or unitl score is ≥ 9.

    Measured: change of Baseline PADSS score up to 24h after surgery or unitl score is ≥ 9

Secondary outcomes (2)
  1. Recurrence rate

    Recurrence rate will be assessed at 12 months post-operatively

    Measured: at 12 month

  2. Quality of Life assessment: EuraHS Quality of Life questionnaire

    Quality of Life assessment using the EuraHS Quality of Life questionnaire. The questionnaire consists of 9 questions. Each question has a scale from 0-10, wherease 0 is considered the best outcome. Total score (max.90) is assessed by summerizing the scale of each question.

    Measured: 1 month and 12 months post-operatively

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted5 Apr 2019
  2. Study start23 Sep 2019
  3. Primary completionDec 2028 (estimated)
  4. Study completionDec 2029 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Diagnosis
Allocation
Randomised
Intervention model
Parallel groups
Masking
Quadruple blind
Who is masked
Participant, Care provider, Investigator, Outcomes assessor
Enrolment
200 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03904888
Sponsor's protocol ID
Coraline Study
Status last verified
Aug 2026
First submitted
19 Mar 2019
Last updated
6 Aug 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing r-TAPP, l-TAPP and local anesthetics in people with Inguinal Hernia, run by Algemeen Ziekenhuis Maria Middelares at 1 site in Belgium.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 6 Aug 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Belgium. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Filip Muysoms, MD,PhD (+32477325710, filip.muysoms@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

change in PADSS score (time frame: change of Baseline PADSS score up to 24h after surgery or unitl score is ≥ 9). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Aug 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in
Clinical Trial NCT03904888 | AzTrials